The PHR Family: The Role of Extracellular Transglycosylases in Shaping Candida albicans Cells.
Laura PopoloGenny DeganiCarlo CamilloniWilliam A FonziPublished in: Journal of fungi (Basel, Switzerland) (2017)
Candida albicans is an opportunistic microorganism that can become a pathogen causing mild superficial mycosis or more severe invasive infections that can be life-threatening for debilitated patients. In the etiology of invasive infections, key factors are the adaptability of C. albicans to the different niches of the human body and the transition from a yeast form to hypha. Hyphal morphology confers high adhesiveness to the host cells, as well as the ability to penetrate into organs. The cell wall plays a crucial role in the morphological changes C. albicans undergoes in response to specific environmental cues. Among the different categories of enzymes involved in the formation of the fungal cell wall, the GH72 family of transglycosylases plays an important assembly role. These enzymes cut and religate β-(1,3)-glucan, the major determinant of cell shape. In C. albicans, the PHR family encodes GH72 enzymes, some of which work in specific environmental conditions. In this review, we will summarize the work from the initial discovery of PHR genes to the study of the pH-dependent expression of PHR1 and PHR2, from the characterization of the gene products to the recent findings concerning the stress response generated by the lack of GH72 activity in C. albicans hyphae.
Keyphrases
- candida albicans
- cell wall
- biofilm formation
- induced apoptosis
- cell cycle arrest
- end stage renal disease
- growth hormone
- ejection fraction
- endothelial cells
- genome wide
- small molecule
- chronic kidney disease
- stem cells
- cell death
- single cell
- endoplasmic reticulum stress
- signaling pathway
- risk assessment
- prognostic factors
- early onset
- gene expression
- cell therapy
- escherichia coli
- genome wide identification
- climate change
- peritoneal dialysis
- pi k akt
- transcription factor
- life cycle
- induced pluripotent stem cells
- binding protein